Global Immunoglobulin Products Market 2016-2020

SKU ID :TNV-10278705 | Published Date: 13-Apr-2016 | No. of pages: 84
PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings • Assumptions PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Plasma products: An overview • Components of blood plasma • Manufacturing process of plasma products • Clinical uses of plasma • Cost of plasma therapeutics PART 06: Regulation of plasma products PART 07: Pipeline portfolio • Information on few pipeline candidates PART 08: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 09: Market segmentation by type of immunoglobulins PART 10: Market segmentation by application • Immunodeficiency diseases • Hypogammaglobulinemia • CIDP • Congenital AIDS • CLL • Myasthenia gravis • MMN • ITP • Kawasaki disease • Guillain–Barré syndrome • Others PART 11: Market segmentation by ROA • IVIG products • SCIG products • IMIG products PART 12: Market segmentation by volume • Market overview • Immunoglobulin products market by volume in Americas • Immunoglobulin products market by volume in EMEA • Immunoglobulin products market by volume in APAC PART 13: Geographical segmentation • Immunoglobulin products market in Americas • Immunoglobulin products market in EMEA • Immunoglobulin products market in APAC PART 14: Market drivers • Growing older population • Increase in individuals with PID • Promising pipeline • Approval of immunoglobulins to treat neuroimmunological disorders • Rise in demand for IVIG therapies PART 15: Impact of drivers PART 16: Market challenges • High cost of therapy • Product recalls by US FDA • Limited plasma fractionation capacity • Post-transfusion adverse reactions • Stringent regulatory guidelines PART 17: Impact of drivers and challenges PART 18: Market trends • Patient assistance programs • Strategic alliances and M&A • Increased use of synthetic/recombinant products • Rise in awareness of PID PART 19: Vendor landscape • Competitive scenario • Market share analysis 2015 • CSL • Baxalta • Grifols • Octapharma • Kedrion • Biotest Pharmaceuticals • Other prominent vendors PART 20: Appendix • List of abbreviations PART 21: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Composition of blood Exhibit 03: Composition of plasma Exhibit 04: Total collection of plasma in US 2010-2014 (in liters) Exhibit 05: Projected fractionation capacity of manufacturing units in US and EU (millions of liters/annum) Exhibit 06: Process of procurement and manufacturing of plasma products Exhibit 07: Regulatory policies of plasma protein therapy lifecycle Exhibit 08: Pipeline molecules for immunoglobulin products Exhibit 09: Pipeline share of immunoglobulin products 2015 Exhibit 10: Global immunoglobulin products market 2015-2020 ($ billions) Exhibit 11: Five forces analysis Exhibit 12: Global immunoglobulin products market segment by type of immunoglobulins Exhibit 13: Global immunoglobulin products market share by type of immunoglobulins 2015 Exhibit 14: Global immunoglobulin products market segmentation by application Exhibit 15: Global immunoglobulin products market share by application Exhibit 16: Global immunoglobulin products market segment by ROA Exhibit 17: Global immunoglobulin products market share by ROA2015 Exhibit 18: Global IVIG products market 2015-2020 ($ billions) Exhibit 19: Global SCIG products market 2015-2020 ($ billions) Exhibit 20: Global IMIG products market 2015-2020 ($ billions) Exhibit 21: Global immunoglobulin products market revenue by ROA 2015-2020 ($ billions) Exhibit 22: Global immunoglobulin products market YoY revenue and growth based on ROA 2015-2020 ($ billions) Exhibit 23: Global immunoglobulin products market by volume 2015 Exhibit 24: Global immunoglobulin products by volume 2015 and 2020 (tons) Exhibit 25: Global immunoglobulin products market by volume 2015-2020 (tons) Exhibit 26: Average immunoglobulin consumption by country (Kilograms per million people) 2012 Exhibit 27: Immunoglobulin products market in Americas by volume 2015-2020 (tons) Exhibit 28: Global immunoglobulin products market by volume 2015-2020 (tons) Exhibit 29: Immunoglobulin products market in EMEA by volume 2015-2020 (tons) Exhibit 30: Global immunoglobulin products market by geography 2015 Exhibit 31: Global immunoglobulin products market revenue by geography 2015-2020 ($ billions) Exhibit 32: Immunoglobulin products market in Americas 2015-2020 ($ billions) Exhibit 33: Immunoglobulin products market in EMEA 2015-2020 ($ billions) Exhibit 34: Immunoglobulin products market in APAC 2015-2020 ($ billions) Exhibit 35: Global immunoglobulin products market YoY revenue and growth based on geography 2015-2020 Exhibit 36: Population aged 60 years and over: World, developed, and developing regions (millions) Exhibit 37: Impact of drivers Exhibit 38: Impact of drivers and challenges Exhibit 39: Global immunoglobulin products market share analysis 2015 Exhibit 40: Market share analysis of top vendors 2015 Exhibit 41: CSL: Immunoglobulins products segmentation Exhibit 42: Key takeaways Exhibit 43: Baxalta: Product categories by revenue 2015 Exhibit 44: Baxalta: YoY revenue comparison of immunoglobulin therapy area 2014 and 2015 Exhibit 45: Baxalta: Geographic segmentation of immunoglobulin therapies by revenue 2015 Exhibit 46: CSL: Key takeaways Exhibit 47: Grifols: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions) Exhibit 48: Grifols: Key takeaways Exhibit 49: Octapharma: Key takeaways Exhibit 50: Kedrion: Key takeaways Exhibit 51: Biotest: Key takeaways
Baxalta, Biotest Pharmaceuticals Corp., CSL Ltd., Grifols SA, Kedrion SpA, Octapharma, Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), Sorrento Therapeutics.
  • PRICE
  • $2500
    $4000

Our Clients